MeSH tree: C16.320.290
A new study has found there is significant scope to increase the number of eye donations from patients cared for in hospice and palliative care settings—donations which are desperately needed for sight-restoring surgeries.
Nov 2, 2023
0
48
Retinal degeneration in the disease retinitis pigmentosa is caused by a family of hereditary mutations that slowly lead to blindness over years or decades. A mouse model of one of these forms of retinitis pigmentosa, RP59, ...
Oct 31, 2023
0
56
A team of Penn State geneticists is pursuing the answers to an age-old question of human biology: the genetic origin of fundamental variations in skin pigmentation between people of different ethnicities. The link between ...
Oct 25, 2023
0
120
When neurobiologist David Corey showed up at a rare disease conference in 2017, he had no idea that he would enter a race against time to develop a treatment for it.
Oct 19, 2023
0
41
There are still many enigmas about the mechanism of action of the CERKL gene, which causes retinitis pigmentosa and other hereditary vision diseases. Now, a team from the University of Barcelona has described how the lack ...
Sep 18, 2023
0
57
The US Federal Trade Commission (FTC) announced an agreement on Friday allowing American drug manufacturer Amgen to proceed with its $28 billion takeover of Horizon Therapeutics.
Sep 1, 2023
0
61
People with albinism often have poor vision. A new study from the Netherlands Institute for Neuroscience reveals the underlying cause.
Aug 8, 2023
0
81
Dr. Alfonso Sabater pulled up two photos of Antonio Vento Carvajal's eyes. One showed cloudy scars covering both eyeballs. The other, taken after months of gene therapy given through eyedrops, revealed no scarring on either ...
Jul 24, 2023
2
798
Researchers have for the first time calculated the lifetime cost of living with an inherited eye disease in Australia as $5.2 million per person. Distressingly, a significant portion of the cost associated with the progressive ...
Jun 19, 2023
0
42
US regulators filed a lawsuit Tuesday to block biopharmaceutical firm Amgen's proposed $28 billion takeover of drug maker Horizon Therapeutics, saying the transaction would harm consumers.
May 16, 2023
0
49
